PAHC
PHIBRO ANIMAL HEALTH CORP
-0.01 (-0.03%)35.29USD52.4K成交股數1.4B市值14.5本益比(近四季)0.9股價營收比+10.3%營收年增(近四季)2026-11-04下次財報
財報 SEC XBRL 申報值 · 美元 · 財年於 6 月結束
逐季數字是 10-Q 的單季值;財年第四季 XBRL 只有年度值,這裡用年度減前三季推算。年增率比的是去年同一會計季。
營收與利潤率近 16 季
稀釋 EPS近 16 季 · 美元
現金流近 16 季
股東回饋近 16 季 · 庫藏股與股利
損益表 逐季 · 最新在左 · 小字是年增率
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營收 | 384M+10% | 374M+21% | 364M+40% | 379M+44% | 348M+39% | 309M+34% | 260M+2% | 263M+7% | 250M | 231M | 255M | 246M |
| 營業成本 | 258M | 241M | 244M | 269M | 243M | 207M | 177M | 184M | 171M | 164M | 178M | 170M |
| 毛利 | 126M+20% | 133M+30% | 120M+43% | 110M+38% | 105M+33% | 102M+50% | 83.5M+9% | 79.6M+5% | 78.6M | 67.7M | 76.7M | 75.5M |
| 毛利率 | 32.8% | 35.5% | 32.9% | 29.0% | 30.1% | 32.9% | 32.1% | 30.2% | 31.5% | 29.3% | 30.1% | 30.7% |
| 研發費用 | – | – | – | – | – | – | – | – | – | – | – | – |
| 銷售管理費用 | 81.0M | 82.3M | 68.5M | 76.3M | 71.1M | 76.3M | 65.8M | 59.7M | 62.9M | 68.5M | 52.9M | 57.0M |
| 營業利益 | 44.7M+33% | 50.3M+97% | 51.3M+190% | 33.7M+69% | 33.5M+113% | 25.5M-3617% | 17.7M-26% | 19.9M+7% | 15.7M | −726K | 23.8M | 18.6M |
| 營業利益率 | 11.6% | 13.5% | 14.1% | 8.9% | 9.6% | 8.3% | 6.8% | 7.6% | 6.3% | -0.3% | 9.3% | 7.6% |
| 稅後淨利 | 24.0M+15% | 27.5M+762% | 26.5M+280% | 17.2M+105% | 20.9M+1539% | 3.2M-140% | 7.0M-39% | 8.4M-16% | 1.3M | −8.0M | 11.5M | 10.0M |
| 淨利率 | 6.3% | 7.3% | 7.3% | 4.5% | 6.0% | 1.0% | 2.7% | 3.2% | 0.5% | -3.5% | 4.5% | 4.1% |
| 稀釋 EPS | 0.59+16% | 0.67+738% | 0.65+282% | 0.43+105% | 0.51+1600% | 0.08-140% | 0.17-39% | 0.21-16% | 0.03 | -0.20 | 0.28 | 0.25 |
| 稀釋股數 | 41.0M | 41.0M | 40.9M | 40.7M | 40.7M | 40.7M | 40.6M | 40.5M | 40.5M | 40.5M | 40.5M | 40.5M |
資產負債表 期末餘額
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 現金與約當現金 | 54.9M | 55.5M | 72.8M | 68.0M | 60.4M | 67.1M | 51.8M | 50.2M | 33.0M | 43.2M | 41.3M | 37.2M |
| 應收帳款 | 222M | 216M | 218M | 228M | 198M | 192M | 161M | 161M | 151M | 149M | 163M | 153M |
| 存貨 | 540M | 517M | 472M | 444M | 448M | 427M | 273M | 282M | 287M | 279M | 278M | 293M |
| 總資產 | 1.4B | 1.4B | 1.4B | 1.4B | 1.3B | 1.3B | 966M | 979M | 973M | 965M | 971M | 965M |
| 有息負債 | 598M | 604M | 610M | 615M | 619M | 623M | 288M | 291M | 298M | 305M | 312M | 273M |
| 總負債 | 1.1B | 1.1B | 1.1B | 1.1B | 1.1B | 1.0B | 708M | 709M | 702M | 691M | 689M | 693M |
| 股東權益 | 362M | 332M | 312M | 286M | 266M | 247M | 259M | 270M | 271M | 273M | 283M | 272M |
| 負債比 | 75.0% | 76.4% | 77.5% | 79.0% | 79.8% | 80.8% | 73.2% | 72.4% | 72.2% | 71.7% | 70.9% | 71.8% |
| 淨現金(現金 − 有息負債) | −543M | −548M | −537M | −547M | −559M | −556M | −236M | −241M | −265M | −262M | −270M | −236M |
現金流量表 單季
| 科目 | 26Q3 | 26Q2 | 26Q1 | 25Q4 | 25Q3 | 25Q2 | 25Q1 | 24Q3 | 24Q2 | 24Q1 | 23Q4 | 23Q3 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 營業現金流 | – | – | 9.3M-26% | – | – | – | 12.6M | – | – | 16.2M | – | – |
| 資本支出 | – | – | 13.8M | – | – | – | 9.6M | – | – | 7.5M | – | – |
| 自由現金流 | – | – | −4.5M-248% | – | – | – | 3.0M | – | – | 8.7M | – | – |
| 折舊攤銷 | 12.4M | 12.9M | 12.8M | 12.4M | 12.6M | 11.6M | 9.0M | 9.2M | 8.9M | 8.9M | 8.6M | 8.5M |
| 買回庫藏股 | – | – | – | – | – | – | – | – | – | – | – | – |
| 現金股利 | – | – | 4.9M | – | – | – | 4.9M | – | – | 4.9M | – | – |
| 自由現金流率 | – | – | -1.2% | – | – | – | 1.2% | – | – | 3.8% | – | – |
營收拆解 2026 年度 10-K 的分部揭露 · 年增對前一年度
業務分部2026 年度 · 1.5B
| Animal Health | 1.2B | 76.6% | +20.7% |
|---|---|---|---|
| Mineral Nutrition | 282M | 18.6% | +11.5% |
| Performance Products | 73.5M | 4.8% | -8.3% |
地區2026 年度 · 1.5B
| 美國 | 877M | 57.8% | +18.5% |
|---|---|---|---|
| Latin America And Canada | 341M | 22.4% | +14.1% |
| 歐洲中東非洲 | 188M | 12.4% | +17.3% |
| 亞太 | 112M | 7.4% | +15.3% |
產品／服務2026 年度 · 1.5B
| Medicated Feed Additives And Others | 811M | 53.4% | +25.4% |
|---|---|---|---|
| Mineral Nutrition | 282M | 18.6% | +11.5% |
| Nutritional Specialties | 195M | 12.8% | +8.8% |
| Vaccines | 156M | 10.3% | +14.0% |
| Performance Products | 73.5M | 4.8% | -8.3% |
| Animal Health 小計 | 1.2B | 76.6% | +20.7% |
各維度的加總不一定等於合併營收:分部有時含內部交易、地區有時只揭露主要國家。挑的是加總最接近合併營收的那個標籤。
年度 10-K
| 財年 | 營收 | 年增 | 稅後淨利 | 淨利率 | 稀釋 EPS | 自由現金流 |
|---|---|---|---|---|---|---|
| FY2026 | 1.5B | +17.1% | 99.7M | 6.6% | 2.43 | 9.9M |
| FY2025 | 1.3B | +27.4% | 48.3M | 3.7% | 1.19 | 41.8M |
| FY2024 | 1.0B | +4.1% | 2.4M | 0.2% | 0.06 | 46.4M |
| FY2023 | 978M | +3.8% | 32.6M | 3.3% | 0.81 | −38.5M |
| FY2022 | 942M | +13.1% | 49.2M | 5.2% | 1.21 | −5.4M |
| FY2021 | 833M | +4.1% | 54.4M | 6.5% | 1.34 | 19.0M |
| FY2020 | 800M | -3.3% | 33.6M | 4.2% | 0.83 | 25.3M |
| FY2019 | 828M | – | 54.7M | 6.6% | 1.35 | 17.3M |